PRCT - Company ID 0001588978
The table below shows PROCEPT BioRobotics Corp's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $83.13M | $83.33M | $79.18M | $69.16M | $58.37M | $53.35M |
| Cost of revenue | $29.18M | $29.32M | $27.44M | $25.00M | $21.46M | $21.87M |
| Gross profit | $53.95M | $54.01M | $51.75M | $44.16M | $36.91M | $31.48M |
| R&D | $21.46M | $18.19M | $17.63M | $16.40M | $16.65M | $17.50M |
PROCEPT BioRobotics Corp reported annual revenue of $308.05M for fiscal year 2025. That is up 37.2% from $224.50M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $7.72M (FY 2020) to $308.05M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $65.09M | $59.01M | $56.30M | $55.20M | $42.69M | $40.81M |
| Operating income | -$32.61M | -$23.19M | -$22.19M | -$27.44M | -$22.43M | -$26.83M |
| Income tax | -$43.00K | - | - | -$47.00K | - | - |
| Net income | -$31.64M | -$21.41M | -$19.58M | -$24.74M | -$20.97M | -$25.63M |
| EPS (diluted) | -$0.56 | -$0.38 | -$0.35 | -$0.45 | -$0.40 | -$0.50 |